145 related articles for article (PubMed ID: 27784743)
41. Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age.
Fritz MA; Guo SM
Fertil Steril; 1987 Apr; 47(4):584-9. PubMed ID: 2436952
[TBL] [Abstract][Full Text] [Related]
42. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
[TBL] [Abstract][Full Text] [Related]
43. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
[TBL] [Abstract][Full Text] [Related]
44. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
45. Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study.
Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
Int J Cancer; 2010 Jan; 126(2):508-14. PubMed ID: 19585556
[TBL] [Abstract][Full Text] [Related]
46. Viability of intrauterine pregnancy in women with pregnancy of unknown location: prediction using human chorionic gonadotropin ratio vs. progesterone.
Bignardi T; Condous G; Kirk E; Van Calster B; Van Huffel S; Timmerman D; Bourne T
Ultrasound Obstet Gynecol; 2010 Jun; 35(6):656-61. PubMed ID: 20503230
[TBL] [Abstract][Full Text] [Related]
47. Beta-human chorionic gonadotropin in cervicovaginal secretions and preterm delivery.
Garshasbi A; Ghazanfari T; Faghih Zadeh S
Int J Gynaecol Obstet; 2004 Sep; 86(3):358-64. PubMed ID: 15325853
[TBL] [Abstract][Full Text] [Related]
48. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
49. A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.
Lyytinen HK; Dyba T; Ylikorkala O; Pukkala EI
Int J Cancer; 2010 Jan; 126(2):483-9. PubMed ID: 19588504
[TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer.
Lukanova A; Toniolo P; Zeleniuch-Jacquotte A; Grankvist K; Wulff M; Arslan AA; Afanasyeva Y; Johansson R; Lenner P; Hallmans G; Wadell G; Lundin E
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2489-93. PubMed ID: 17132766
[TBL] [Abstract][Full Text] [Related]
51. Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study.
Wirleitner B; Schuff M; Vanderzwalmen P; Stecher A; Okhowat J; Hradecký L; Kohoutek T; Králícková M; Spitzer D; Zech NH
Reprod Biol Endocrinol; 2015 Jul; 13():70. PubMed ID: 26141379
[TBL] [Abstract][Full Text] [Related]
52. Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels.
Guha S; Ayim F; Ludlow J; Sayasneh A; Condous G; Kirk E; Stalder C; Timmerman D; Bourne T; Van Calster B
Hum Reprod; 2014 May; 29(5):938-45. PubMed ID: 24634251
[TBL] [Abstract][Full Text] [Related]
53. Norplant implants: the mechanism of contraceptive action.
Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
[TBL] [Abstract][Full Text] [Related]
54. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Richardson BE; Peck JD; Wormuth JK
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
[TBL] [Abstract][Full Text] [Related]
55. Maternal risk of breast cancer following multiple births: a nationwide study in Sweden.
Lambe M; Hsieh C; Tsaih S; Ekbom A; Adami HO; Trichopoulos D
Cancer Causes Control; 1996 Sep; 7(5):533-8. PubMed ID: 8877051
[TBL] [Abstract][Full Text] [Related]
56. Serum hCG assay: a method for detection of contamination of fetal blood samples.
Dommergues M; Bunduki V; Muller F; Mandelbrot L; Morichon-Delvallez N; Dumez Y
Prenat Diagn; 1993 Nov; 13(11):1043-6. PubMed ID: 8140067
[TBL] [Abstract][Full Text] [Related]
57. Does full-term pregnancy at a young age protect women against breast cancer through hCG?
Rao CV
Obstet Gynecol; 2000 Nov; 96(5 Pt 1):783-6. PubMed ID: 11042318
[TBL] [Abstract][Full Text] [Related]
58. alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Melbye M; Wohlfahrt J; Lei U; Nørgaard-Pedersen B; Mouridsen HT; Lambe M; Michels KB
J Natl Cancer Inst; 2000 Jun; 92(12):1001-5. PubMed ID: 10861312
[TBL] [Abstract][Full Text] [Related]
59. A prospective, randomized study of the chorionic gonadotropin-time relationship in early gestation: clinical implications.
Kadar N; Bohrer M; Kemman E; Shelden R
Fertil Steril; 1993 Sep; 60(3):409-12. PubMed ID: 8375517
[TBL] [Abstract][Full Text] [Related]
60. Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.
Chen Y; Kibriya MG; Jasmine F; Santella RM; Senie RT; Ahsan H
Cancer Res; 2008 Dec; 68(23):9729-34. PubMed ID: 19047151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
